Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Data presented as a “Top-rated Abstract in Head and Neck Cancer” at the 2025 Annual Meeting of the American Society for Radiation Oncology (ASTRO) on September 29th
TREMFYA® is now approved for pediatric patients living with moderate to severe plaque psoriasis, who are candidates for systemic therapy or phototherapy, and active psoriatic arthritis in children s
Why Johnson & Johnson Could Be the Ultimate Dividend King
06:15pm, Sunday, 28'th Sep 2025
Some stocks simply pay a regular dividend. The smarter ones also raise their dividend payout every year, putting more cash in their shareholders' pockets.
Best Dividend Aristocrats For October 2025
01:00am, Sunday, 28'th Sep 2025
Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date, with notable dispersion among individual stock returns. Dividend growth remains robust, with 55 of 69 Aristoc
'I'm an optimist,' says Johnson & Johnson CEO on its R&D investment
10:18pm, Friday, 26'th Sep 2025
CNBC's Jim Cramer sits down with Johnson & Johnson CEO Joaquin Duato to talk about the company's outlook, President Trump's 100% tariff on some pharmaceutical imports, cancer treatment innovation and
Watch Jim Cramer's interview with Johnson & Johnson CEO Joaquin Duato
08:43pm, Friday, 26'th Sep 2025
CNBC's Jim Cramer sits down with Johnson & Johnson CEO Joaquin Duato to talk about the company's outlook, President Trump's 100% tariff on some pharmaceutical imports, cancer treatment innovation and
Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing
06:46pm, Friday, 26'th Sep 2025
Johnson & Johnson (JNJ) closed at $179.71 in the latest trading session, marking a +1.11% move from the prior day.
Could This Single Dividend King Make Your Portfolio Worth $1 Million in 20 Years?
07:21am, Friday, 26'th Sep 2025
Johnson & Johnson (JNJ 0.57%) is a longtime healthcare leader with numerous positive qualities. These include its 62 consecutive years of dividend increases, which surpass the 50 required to be recogn
Johnson & Johnson (JNJ) Could Be a Great Choice
12:46pm, Thursday, 25'th Sep 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
10:00am, Thursday, 25'th Sep 2025
Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.
These 3 Dow Stocks Are Set to Soar in 2025 and Beyond
04:52am, Thursday, 25'th Sep 2025
The Dow Jones Industrial Average (^DJI -0.37%) hasn't been the stock market's go-to index for a long, long time. It's since been replaced by the broader S&P 500 (^GSPC -0.28%), and for tech-minded gro
3 Exceptional High-Yielding Dividend Kings That Have Been Increasing Their Payouts for Over 60 Years
03:15am, Thursday, 25'th Sep 2025
Stocks that pay dividends can make for great long-term investments. The best reason to invest in them is that they can generate recurring cash flow for you on an ongoing basis.
Johnson & Johnson (JNJ) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript
05:17pm, Wednesday, 24'th Sep 2025
Johnson & Johnson (NYSE:JNJ ) Bernstein 2nd Annual Global Healthcare Conference September 24, 2025 1:10 PM EDT Company Participants Tom Cavanaugh - Company Group Chairman for North America Innovative
Should You Invest in Johnson & Johnson (JNJ) Based on Bullish Wall Street Views?
10:31am, Wednesday, 24'th Sep 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
J&J to withdraw acid reflux device from non-US markets, Bloomberg News reports
05:52am, Tuesday, 23'rd Sep 2025
Johnson & Johnson will withdraw a device to treat acid reflux disease from markets outside the U.S., Bloomberg News reported on Tuesday, citing a company letter sent to doctors.
